Skip to content

Exercise on Prescription

Exercise on prescription: A study for paediatric patients with neurocognitive impairment - Exercise on Prescription

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON58154
Enrollment
128
Registered
2025-02-04
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurocognitive impairment cognitive problems, memory and concentration problems

Interventions

Paediatric patients aged 6–18 years who exhibit neurocognitive impairment and do not meet physical activity guidelines. This study will start by including children with congenital heart disease who un

Sponsors

Amsterdam UMC
Lead Sponsor

Eligibility

Age
2 Years to 17 Years

Inclusion criteria

Inclusion criteria: In order to be eligible to participate in this study, a participant must meet all of the following criteria:Does not meet the physical activity guideline (at least one hour of moderate-to-vigorous intensity physical activity daily, including muscle- and bone-strengthening activities at least three times per week);Has a neurocognitive functioning impairment (<5th percentile in at least 1 neurocognitive domain);Experiences neurocognitive problems as reported by parents;Is fluent in Dutch and inhabitant of the Netherlands. Specific for children with congenital heart disease:Underwent open-heart surgery before the age of one year;Is aged 6–18 years at the time of inclusion in the study;Has a physical cardiovascular fitness deficit (impaired exercise tolerance) as measured by VO2 max (< -1 SD).

Exclusion criteria

Exclusion criteria: A potential participant who meets any of the following criteria will be excluded from participation in this study:Absence or withdrawal of written informed consent;Contraindications for physical activity as assessed by treating physician;Inability to comprehend testing instructions;Patient had opt-out for re-use of clinical data for research.

Design outcomes

Primary

MeasureTime frame
The primary endpoint is neurocognitive functioning, measured in seven domains: Speed, Stability, Attention & Control, Memory, Verbal Working Memory, Visual Working Memory and Visuomotor Integration.

Secondary

MeasureTime frame
Secondary endpoints include physical cardiovascular fitness, physical activity, behavioural and emotional functioning, sleep quality and self-esteem.

Countries

Netherlands

Contacts

Public ContactJ. Oosterlaan

Amsterdam UMC

bewegenoprecept@amsterdamumc.nl020-5669111

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)